Compounds > argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-
Page last updated: 2024-09-05

argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- and quinoxalines

argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- has been researched along with quinoxalines in 1 studies

Compound Research Comparison

Studies
(argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-)		Trials
(argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-)		Recent Studies (post-2010)
(argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-)		Studies
(quinoxalines)		Trials
(quinoxalines)		Recent Studies (post-2010) (quinoxalines)
14029,8876253,095

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antunes-Rodrigues, J; Busnardo, C; Corrêa, FM; Tavares, RF1

Other Studies

1 other study(ies) available for argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- and quinoxalines

ArticleYear
Cardiovascular effects of L-glutamate microinjection in the supraoptic nucleus of unanaesthetized rats.
    Neuropharmacology, 2007, Volume: 52, Issue:6

    Topics: Animals; Arginine Vasopressin; Blood Pressure; Excitatory Amino Acid Antagonists; Ganglionic Blockers; Glutamic Acid; Heart Rate; Isoquinolines; Male; Microinjections; Pentolinium Tartrate; Quinoxalines; Rats; Rats, Wistar; Supraoptic Nucleus; Vasopressins

2007